North America Facial Injectables Market: Botulinum Toxin to Rise at a CAGR of 12.7% During 2016-2024
The North America facial injectables market is quite monopolistic in nature with one player dominating the overall market dynamics. As of 2016, Allergan Plc., held a share 62.0% in the regional market. The company dominance is a result of the strong brand value of its drugs like Botox & Juvederm. Presently, Botox is leading the market and is expected to retain its stance all throughout 2024.
View full press release